{"id":"cu-40102-spray","safety":{"commonSideEffects":[]},"_chembl":null,"_dailymed":null,"mechanism":{"_ai_source":"claude-haiku-4.5","explanation":"As a spray formulation, CU-40102 delivers medication directly to the skin surface, allowing for localized therapeutic action while minimizing systemic exposure. The specific mechanism depends on the active ingredient, which is not publicly disclosed in available sources. The spray format enables convenient application and potentially improved patient compliance for dermatological treatment.","oneSentence":"CU-40102 is a topical spray formulation designed to treat skin conditions, likely through local delivery of an active pharmaceutical ingredient to affected areas.","_ai_confidence":"low"},"_scrapedAt":"2026-03-28T01:08:14.197Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Dermatological condition (specific indication not publicly disclosed)"}]},"trialDetails":[{"nctId":"NCT05135468","phase":"PHASE3","title":"A Phase 3 Clinical Study Patients With Androgenetic Alopecia (AGA)","status":"COMPLETED","sponsor":"Cutia Therapeutics（Wuxi）Co.,Ltd","startDate":"2021-12-06","conditions":"AGA","enrollment":270}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":0,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":[],"phase":"phase_3","status":"active","brandName":"CU-40102 Spray","genericName":"CU-40102 Spray","companyName":"Cutia Therapeutics（Wuxi）Co.,Ltd","companyId":"cutia-therapeutics-wuxi-co-ltd","modality":"Small molecule","firstApprovalDate":"","aiSummary":"CU-40102 is a topical spray formulation designed to treat skin conditions, likely through local delivery of an active pharmaceutical ingredient to affected areas. Used for Dermatological condition (specific indication not publicly disclosed).","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":0,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":false,"trials":true,"score":3}}